Risk of CT-induced cancer minimal compared to risk of dying from disease

May 1, 2012, American Roentgen Ray Society

Young patients who undergo chest or abdominopelvic CT are more than 35 times more likely to die of their disease than develop a radiation induced cancer, according to an analysis of 23,359 patients, some of whom were scanned more than 15 times.

The analysis conducted at three hospitals in Boston, found that in the chest CT group, 575 out of 8,133 patients were deceased after a mean follow-up of about 4 years. "That compares to the 12 cases of radiation-induced cancer that would be expected in this group based on the BEIR-VII method, a commonly used model for determining CT-induced ," said Rob Zondervan, one of the authors of the study.

In the abdomino-pelvic CT group, 1,124 out of 15,226 patients were deceased after a mean follow-up of about 3.5 years. "That compares to 23 cases of predicted cancer incidence," said Mr. Zondervan. "Our results indicate that the risk from underlying disease overshadows risk from CT radiation-induced malignancy, even in young adults," he said.

Records of all patients aged 18-35 who underwent a or an abdominopelvic CT from 2003-2007 were included in the analysis.

The data was broken down further based on number of . Patients who had only one or two scans had the most predicted cases of CT-induced (20 out of the 35 predicted cases). "This seeming anomaly arises from the much greater number of young adults who get one or two scans," said Mr. Zondervan. "These results do emphasize that we need to focus our radiation reduction efforts on patients who are very rarely scanned as well as those who are more frequently scanned," he said.

The analysis will be presented at the ARRS Annual Meeting May 1 in Vancouver, Canada.

Explore further: Experts offer pointers for optimizing radiation dose in chest CT

Related Stories

Experts offer pointers for optimizing radiation dose in chest CT

September 1, 2011
An article in the September issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in chest computed tomography (CT) scans. Chest CT is the third most commonly performed ...

Breast shields better at reducing dose than posteriorly centered partial CT, study finds

May 4, 2011
The use of breast shields is the technique of choice to protect the breasts of women from radiation exposure while undergoing chest CT examinations, according to a new study.

Researchers find little secondary cancer risk from multi-detector CT scans in Medicare population

April 2, 2012
The secondary cancer risk from multi-detector computed tomography (MDCT) scans is low among older adults, according to a study from Stanford University in the April issue of the Journal of the American College of Radiology. ...

Recommended for you

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.